About Us
Research Watch
स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छनेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकटFrontline Perspectives on Nursing Leadership in NepalProtecting the Smallest Lungs from the Hidden Grip of RSV in KathmanduThe Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsस्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छनेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकटFrontline Perspectives on Nursing Leadership in NepalProtecting the Smallest Lungs from the Hidden Grip of RSV in KathmanduThe Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

The Accuracy of the I2 Statistic for Detecting Baseline Imbalances and Selection Bias in Randomized Controlled Trials: A Simulation Study.

Researchers

Steffen Mickenautsch, Veerasamy Yengopal

Abstract

To assess the accuracy of the I<sup>2</sup> statistic, applied as a trial-adjusted, simulated comparator trials (SCTs) based I<sup>2</sup> test for detecting baseline imbalances and selection bias in randomized controlled trials (RCTs). Fifty non-biased and 50 biased trials set at 40% selection bias severity were simulated in MS Excel (Microsoft Corporation, Redmond, Washington, USA). All trials were tested using statistical significance testing and the I<sup>2</sup> test. Null hypotheses were tested that the sensitivities and specificities of both tests did not statistically significantly differ and that the selection bias category scores, established by the I<sup>2</sup> test, do not statistically significantly correlate with the p-values from statistical significance testing. McNemar test and Spearman's rank correlation were used. The risk of the I<sup>2</sup> test overestimating selection bias severity was also examined. I<sup>2</sup> test demonstrated higher sensitivity than significance testing for detecting both baseline imbalance and selection bias (p &lt; 0.0001). Specificity for baseline imbalance detection was identical at 100% for both methods; 95% CI: 90%-100%. For selection bias, specificity was greater with significance testing than with the I&#xb2; test (p = 0.0005). A significant negative, large (0.5 &#x2264; |r|) correlation emerged between I&#xb2; scores and significance test p-values: Spearman's r = -0.61, p &lt; 0.0001. All null hypotheses, with the exception of the test specificities for baseline imbalance detection, were rejected. The I<sup>2</sup> test caused 26% of 'true positive' trials to be over-classified by one severity category. &#xa0;The I<sup>2</sup> test was significantly more accurate for identifying baseline imbalance and selection bias detection, and equally accurate for ruling out baseline&#xa0;imbalance compared with statistical significance testing. However, the I<sup>2</sup> test was significantly less accurate in detecting selection bias absence. The I<sup>2</sup> test's bias category scores were largely negatively associated with p-values and tended to overestimate bias severity. Negative I<sup>2</sup> test results appear reliable for ruling out baseline imbalances and selection bias in RCTs, while positive I<sup>2</sup> test results are highly accurate to detect baseline imbalances but should be interpreted cautiously when assessing selection bias.
Source: PubMed (PMID: 42604264)View Original on PubMed